Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON

BACKGROUND: GIDEON was a prospective, global, non-interventional study evaluating the safety of sorafenib in patients with unresectable hepatocellular carcinoma in real-world practice. The aim of this subgroup analysis was to assess the safety and efficacy of sorafenib as used by Japanese patients....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Gastroenterol
Hlavní autoři: Kudo, Masatoshi, Ikeda, Masafumi, Takayama, Tadatoshi, Numata, Kazushi, Izumi, Namiki, Furuse, Junji, Okusaka, Takuji, Kadoya, Masumi, Yamashita, Satoshi, Ito, Yuichiro, Kokudo, Norihiro
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Japan 2016
Témata:
Original Article—Liver, Pancreas, and Biliary Tract
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5121182/
https://ncbi.nlm.nih.gov/pubmed/27106231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-016-1204-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky